)
Visual
test
Lifeward
Lifeward (LFWD) investor relations material
Lifeward Q4 2025 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Q4 2025 earnings summary18 Mar, 2026
Executive summary
Executing a strategy to become a leading diversified biomedical innovation company with platforms in neurorehabilitation, robotics, and metabolic therapeutics, advanced by acquiring Oramed's oral protein delivery technology and powered upper-body exoskeleton platform.
Strategic partnership with Oramed provides access to capital, up to $47 million in funding, and adds an advanced oral insulin candidate to the portfolio.
Acquisition of Skelable technology and team expands into upper extremity neurorehabilitation, complementing the ReWalk ecosystem.
Expanded reimbursement coverage for ReWalk Personal Exoskeleton with major U.S. payers and international distribution growth.
Focused on scaling through reimbursement progress, commercial execution, and product innovation.
Financial highlights
2025 revenue was $22 million, down 14% year-over-year; Q4 2025 revenue was $5.1 million, down 33% from Q4 2024.
ReWalk Personal Exoskeleton revenue stable at $8.5 million, with 22% increase in units sold year-over-year; Q4 sales rose 20% to $1.8 million.
AlterG revenue declined 18% to $12.9 million for the year and 43% in Q4, mainly due to timing of distributor orders.
Gross profit increased to $8.4 million (38.2% margin), up from $8.2 million (32%) in 2024; non-GAAP gross profit was $9 million (41% margin); adjusted gross margin for 2025 was 40.9%.
Operating expenses fell 25% to $28.1 million, with adjusted operating expenses down 12%; operating loss narrowed by 33% to $19.7 million.
Outlook and guidance
Strategic transaction with Oramed expected to close soon, providing additional funding and a cash runway.
Commercial launch of upper-body exoskeleton anticipated in 18–24 months, with expectations for attractive gross margins.
Anticipates continued improvements in operating expenses and growth in core med tech business to drive toward positive cash flow.
No formal guidance provided due to significant transformation and pending Oramed transaction.
Synergies between medtech and oral insulin
Regulatory path for the Skelable technology
Impact of Medicare Advantage coverage expansion
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Latest events from Lifeward
- Shareholders to vote on acquisition, major share issuances, and board changes, enabling new growth.LFWD
Proxy Filing9 Feb 2026 - Q2 revenue soared 400%+ to $6.7M, with Medicare and AlterG fueling growth and narrowed losses.LFWDQ2 20242 Feb 2026
- Shareholders to vote on transformative acquisition, financings, and board changes, with major dilution.LFWDProxy Filing28 Jan 2026
- Q3 revenue up 39% year-over-year, margins improved, and net loss narrowed to $3.1M.LFWDQ3 202415 Jan 2026
- Medical device firm seeks to raise $100M for growth via shelf offering of shares, warrants, and debt.LFWDRegistration Filing2 Jan 2026
- Record revenue, margin gains, and partnerships drive 2025 growth and profitability focus.LFWDQ4 202426 Dec 2025
- Medical device firm seeks to raise up to $100M via flexible shelf registration for growth.LFWDRegistration Filing16 Dec 2025
- Shareholders to vote on par value elimination, new incentive plan, and CEO equity grant.LFWDProxy Filing2 Dec 2025
- Shareholders will vote on director elections, compensation, new equity plan, and capital increase.LFWDProxy Filing2 Dec 2025
Next Lifeward earnings date
Q1 202614 May, 2026
Lifeward
Next Lifeward earnings date
Q1 202614 May, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
Explore our global coverage